Project: Research project

Project Details


Pathophysiological processes that affect the brain produce alterations of
metabolites which can be detected by Magnetic Resonance Spectroscopy (MRS).
The goals of this project are to develop improved MR spectroscopic imaging
(SI) techniques to measure the distribution of these metabolites in vivo
and to evaluate MR SI techniques for diagnosis and prognosis of stroke. 1H
and 31P MR SI techniques are proposed for the observation of lactate, amino
acids (N-Acetylaspartate, Glutamate, Taurine, GABA) and other metabolite
distributions. Alteration of in vivo metabolite distributions with
temporary and permanent focal cerebral ischemia will be monitored in the
rat. These studies will investigate i) the importance of lactate as a
marker of ischemia, ii) that decreased NAA is a marker of neuronal damage,
and iii) increased levels of glutamate and other Excitatory Amino Acids
cause delayed tissue damage. Results of this work will be incorporated
within ongoing clinical spectroscopy studies of stroke.

Improvements to the Fourier method of spectroscopic imaging are proposed,
including; i) increasing the information content of the SI acquisition
using short TE, spin editing and 3D imaging, ii) improved data processing
to remove a number of instrumental problems, iii) improved spectral
analysis techniques for quantitation of metabolite concentrations.
Processing and display utilities will be further developed to facilitate
rapid analysis and review of SI data.
Effective start/end date12/15/9711/30/01


  • National Institute of Neurological Disorders and Stroke: $418,419.00
  • National Institute of Neurological Disorders and Stroke
  • National Institute of Neurological Disorders and Stroke


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.